Interleukin-1 contributes to neuronal injury via cell-specific IL-1 type 1 receptor-mediated actions after cerebral ischemia

被引：0
|
作者：
Lenart, N. [1 ]
Wong, R. [2 ]
Martinecz, B. [1 ]
Coutts, G. [2 ]
Waisman, A. [3 ]
Muller, W. [2 ]
Allen, S. [2 ]
Pinteaux, E. [2 ]
Denes, A. [1 ,2 ]
机构：
[1] Hungarian Acad Sci, Inst Expt Med Mol & Dev Neurobiol, Lab Neuroimmunol, Budapest, Hungary
[2] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
[3] Inst Mol Med, Mainz, Germany
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2017年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BS01-4
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [31] INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST BINDS TO THE 80-KDA IL-1 RECEPTOR BUT DOES NOT INITIATE IL-1 SIGNAL TRANSDUCTION
    DRIPPS, DJ
    BRANDHUBER, BJ
    THOMPSON, RC
    EISENBERG, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (16) : 10331 - 10336
  • [32] Polymorphisms for interleukin-1β (IL-1β)-511 promoter, IL-1β exon 5, and IL-1 receptor antagonist:: Nonassociation with endometriosis
    Hsieh, YY
    Chang, CC
    Tsai, FJ
    Wu, JY
    Shi, YR
    Tsai, HD
    Tsai, CH
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2001, 18 (09) : 506 - 511
  • [33] BLOCKING IL-1 - INTERLEUKIN-1 RECEPTOR ANTAGONIST INVIVO AND INVITRO
    DINARELLO, CA
    THOMPSON, RC
    IMMUNOLOGY TODAY, 1991, 12 (11): : 404 - 410
  • [34] Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid
    Rawlinson, A
    Dalati, MHN
    Rahman, S
    Walsh, TF
    Fairclough, AL
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2000, 27 (10) : 738 - 743
  • [35] The pattern of interleukin-1 beta (IL-1 beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections
    vanDeuren, M
    vanderVenJongekrijg, J
    Vannier, E
    vanDalen, R
    Pesman, G
    Bartelink, AKM
    Dinarello, CA
    vanderMeer, JWM
    BLOOD, 1997, 90 (03) : 1101 - 1108
  • [36] Soluble type-I interleukin-1 receptor blocks chicken IL-1 activity
    Klasing, KC
    Peng, RK
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2001, 25 (04): : 345 - 352
  • [37] Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes
    Luotola, K.
    Pietila, A.
    Zeller, T.
    Moilanen, L.
    Kahonen, M.
    Nieminen, M. S.
    Kesaniemi, Y. A.
    Blankenberg, S.
    Jula, A.
    Perola, M.
    Salomaa, V.
    JOURNAL OF INTERNAL MEDICINE, 2011, 269 (03) : 322 - 332
  • [38] Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia
    Pinteaux, E
    Rothwell, NJ
    Boutin, H
    GLIA, 2006, 53 (05) : 551 - 556
  • [39] RECEPTOR-MEDIATED ENDOCYTOSIS AND INTRACELLULAR FATE OF INTERLEUKIN-1
    SOLARI, R
    SMITHERS, N
    KENNARD, N
    RAY, K
    GRENFELL, S
    BIOCHEMICAL PHARMACOLOGY, 1994, 47 (01) : 93 - 101
  • [40] THE ROLE OF INTERLEUKIN-1 (IL-1) AND IL-1 RECEPTOR ANTAGONIST IN GRAFT-VERSUS-HOST DISEASE
    FERRARA, JLM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 96 - 96
12345